본문 바로가기
KERD
논문KCI 등재

Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals

Mark Muthiah|Apichat Kaewdech|Darren Jun Hao Tan|Cheng Han Ng|Kai En Chan|Wen Hui Lim|Jingxuan Quek|Ansel Shao Pin Tang|Jieling Xiao|Phoebe Tay|Margaret Teng|Keng Siang Lee|Snow Yunni Lin|May Zin Myint|Benjamin Tan|Vijay K Sharma|Daniel Huang|Nicholas WS Chew|Mohammad Shadab Siddiqui|Arun J Sanyal
대한간학회 (The korean Association for the Study of the Liver)|2022.07|Clinical and Molecular Hepatology|제28권 제3호|pp. 483-496|DOI 10.3350/cmh.2021.0406

0

조회

0

다운로드

4

인용

0

참고문헌

키워드

StrokeAtherosclerosisIschemic strokeNonalcoholic fatty liver disease

초록

Background/Aims: Non-alcoholic fatty liver disease (NAFLD) is associated with the development of cardiovascular disease. While existing studies have examined cardiac remodeling in NAFLD, there has been less emphasis on the development of carotid atherosclerosis and stroke. We sought to conduct a meta-analysis to quantify the prevalence, risk factors, and degree of risk increment of carotid atherosclerosis and stroke in NAFLD. Methods: Embase and Medline were searched for articles relating to NAFLD, carotid atherosclerosis, and stroke. Proportional data was analysed using a generalized linear mixed model. Pairwise meta-analysis was conducted to obtain odds ratio or weighted mean difference for comparison between patients with and without NAFLD. Results: From pooled analysis of 30 studies involving 7,951 patients with NAFLD, 35.02% (95% confidence interval [CI], 27.36–43.53%) had carotid atherosclerosis with an odds ratio of 3.20 (95% CI, 2.37–4.32; P<0.0001). Pooled analysis of 25,839 patients with NAFLD found the prevalence of stroke to be 5.04% (95% CI, 2.74–9.09%) with an odds ratio of 1.88 (95% CI, 1.23–2.88; P=0.02) compared to non-NAFLD. The degree of steatosis assessed by ultrasonography in NAFLD was closely associated with risk of carotid atherosclerosis and stroke. Older age significantly increased the risk of developing carotid atherosclerosis, but not stroke in NAFLD. Conclusions: This meta-analysis shows that a stepwise increment of steatosis of NAFLD can significantly increase the risk of carotid atherosclerosis and stroke development in NAFLD. Patients more than a third sufferred from carotid atherosclerosis and routine assessment of carotid atherosclerosis is quintessential in NAFLD.

Abstract

Background/Aims: Non-alcoholic fatty liver disease (NAFLD) is associated with the development of cardiovascular disease. While existing studies have examined cardiac remodeling in NAFLD, there has been less emphasis on the development of carotid atherosclerosis and stroke. We sought to conduct a meta-analysis to quantify the prevalence, risk factors, and degree of risk increment of carotid atherosclerosis and stroke in NAFLD. Methods: Embase and Medline were searched for articles relating to NAFLD, carotid atherosclerosis, and stroke. Proportional data was analysed using a generalized linear mixed model. Pairwise meta-analysis was conducted to obtain odds ratio or weighted mean difference for comparison between patients with and without NAFLD. Results: From pooled analysis of 30 studies involving 7,951 patients with NAFLD, 35.02% (95% confidence interval [CI], 27.36–43.53%) had carotid atherosclerosis with an odds ratio of 3.20 (95% CI, 2.37–4.32; P<0.0001). Pooled analysis of 25,839 patients with NAFLD found the prevalence of stroke to be 5.04% (95% CI, 2.74–9.09%) with an odds ratio of 1.88 (95% CI, 1.23–2.88; P=0.02) compared to non-NAFLD. The degree of steatosis assessed by ultrasonography in NAFLD was closely associated with risk of carotid atherosclerosis and stroke. Older age significantly increased the risk of developing carotid atherosclerosis, but not stroke in NAFLD. Conclusions: This meta-analysis shows that a stepwise increment of steatosis of NAFLD can significantly increase the risk of carotid atherosclerosis and stroke development in NAFLD. Patients more than a third sufferred from carotid atherosclerosis and routine assessment of carotid atherosclerosis is quintessential in NAFLD.

참고문헌 (109)

  1. Grace En Hui Lim, "An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD", Clinical Gastroenterology and Hepatology, 21(3), pp.619~629.e7 (2021), Elsevier BV[DOI]
  2. Huang DQ, "Global epidemiology of NAFLD-related HCC : trends, predictions, risk factors and prevention", Nat Rev Gastroenterol Hepatol, 18, pp.223~238 (2021)
  3. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 67, pp.328~357 (2018)
  4. Wong C, "Sodium-glucose co-transporter 2 inhibitors for non-alcoholic fatty liver disease in Asian patients with type 2 diabetes: a meta-analysis", Front Endocrinol(Lausanne), 11, pp.609135~ (2021)
  5. Li B, "Nonalcoholic fatty liver disease cirrhosis : a review of its epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis", Can J Gastroenterol Hepatol, 2018, pp.2784537~ (2018)
  6. Michelotti GA, "NAFLD, NASH and liver cancer", Nat Rev Gastroenterol Hepatol, 10, pp.656~665 (2013)
  7. Muthiah MD, "A clinical overview of non-alcoholic fatty liver disease : a guide to diagnosis, the clinical features, and complications-What the non-specialist needs to know", Diabetes Obes Metab, 24(2), pp.3~14 (2022)
  8. Xiao J, "Is fatty liver associated with depression? A meta-analysis and systematic review on the prevalence, risk factors, and outcomes of depression and non-alcoholic fatty liver disease", Front Med(Lausanne), 8, pp.691696~ (2021)
  9. Muthiah MD, "A clinical overview of non-alcoholic fatty liver disease : a guide to diagnosis, the clinical features, and complications-what the non-specialist needs to know", Diabetes Obes Metab, 24(2), pp.3~14 (2022)
  10. Jonathan Zhi Kai Toh, "A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease", Clinical Gastroenterology and Hepatology, 20(11), pp.2462~2473.e10 (2022), Elsevier BV[DOI]
  11. Zou Y, "Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes", Intern Med J, 47, pp.1147~1153 (2017)
  12. Hmwe Hmwe Kyu, "Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017", The Lancet, 392(10159), pp.1859~1922 (2018), Elsevier BV[DOI]
  13. Hopewell JC, "Emerging risk factors for stroke : what have we learned from mendelian randomization studies?", Stroke, 47, pp.1673~1678 (2016)
  14. Hu J, "Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease : a meta-analysis", Oncotarget, 9, pp.2752~2760 (2017)
  15. Ampuero J, "Association of NAFLD with subclinical atherosclerosis and coronary-artery disease : meta-analysis", Rev Esp Enferm Dig, 107, pp.10~16 (2015)
  16. Zhou YY, "Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis : a systematic review and meta-analysis", Hepatol Commun, 2, pp.376~392 (2018)
  17. Veracruz N, "The association between nonalcoholic fatty liver disease and risk of cardiovascular disease, stroke, and extrahepatic cancers", J Clin Exp Hepatol, 11, pp.45~81 (2021)
  18. Madan SA, "Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults : a meta-analysis", Eur J Gastroenterol Hepatol, 27, pp.1237~1248 (2015)
  19. Heiss G, "Carotid atherosclerosis measured by B-mode ultrasound in populations : associations with cardiovascular risk factors in the ARIC study", Am J Epidemiol, 134, pp.250~256 (1991)
  20. Al Rifai M, "The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis : the multi-ethnic study of atherosclerosis(MESA)", Atherosclerosis, 239, pp.629~633 (2015)
  21. Idilman IS, "Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients : a computed tomography angiography study 2", J Diabetes, 7, pp.279~286 (2015)
  22. Wan X, "Estimating the sample mean and standard deviation from the sample size, median, range and", or interquartile range, 2014, pp.14, 135~
  23. DerSimonian R, "Meta-analysis in clinical trials", Control Clin Trials, 7, pp.177~188 (1986)
  24. Fletcher J, "What is heterogeneity and is it important?", BMJ, 334, pp.94~96 (2007)
  25. Bell A, "Fixed and random effects models : making an informed choice", Qual Quant, 53, pp.1051~1074 (2019)
  26. Tufanaru C, "Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness", Int J Evid Based Healthc, 13, pp.196~207 (2015)
  27. Clopper CJ, "The use of confidence or fiducial limits illustrated in the case of the binomial", Biometrika, 26, pp.404~413 (1934)
  28. Schwarzer G, "Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions", Res Synth Methods, 10, pp.476~483 (2019)
  29. Ng CH, "A diagnostic test meta-analysis evaluating imaging-based and blood biomarker-based assessment tools for fibrosis after liver transplantation", Liver Transpl, 28, pp.659~669 (2022)
  30. Munn Z, "The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence", Int J Health Policy Manag, 3, pp.123~128 (2014)
  31. Taharboucht S, "Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease : a case-control study in Algerian population", J Med Vasc, 46, pp.129~138 (2021)
  32. Guo K, "Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes", J Diabetes Complications, 31, pp.80~85 (2017)
  33. Huang Y, "Nonalcoholic fatty liver disease is associated with atherosclerosis in middleaged and elderly Chinese", Arterioscler Thromb Vasc Biol, 32, pp.2321~2326 (2012)
  34. Li X, "Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease", J Hypertens, 35, pp.1226~1234 (2017)
  35. Tu S, "Association between non-alcoholic fatty liver disease and intracerebral hemorrhage", Cell Transplant, 28, pp.1033~1038 (2019)
  36. Wang B, "Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease", Diabetes Res Clin Pract, 177, pp.108873~ (2021)
  37. Xu J, "Severity of nonalcoholic fatty liver disease and risk of future ischemic stroke events", Stroke, 52, pp.103~110 (2021)
  38. Zhang L, "Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness in type 1 diabetic patients", Sci Rep, 6, pp.26805~ (2016)
  39. Zheng J, "Association between nonalcoholic fatty liver disease and subclinical atherosclerosis : a cross-sectional study on population over 40years old", BMC Cardiovasc Disord, 18, pp.147~ (2018)
  40. Mikolasevic I, "Nonalcoholic fatty liver disease(NAFLD)and cardiovascular risk in renal transplant recipients", Kidney Blood Press Res, 39, pp.308~314 (2014)
  41. Assem M, "Hypoadiponectinemia as a marker of increased cardiovascular risk in patients with non-alcoholic fatty liver disease : correlation with albumin", creatinine ratio, 2021, pp.65, 93~97
  42. El Azeem HA, "Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events", J Saudi Heart Assoc, 25, pp.239~246 (2013)
  43. Tziomalos K, "Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome", World J Hepatol, 5, pp.621~626 (2013)
  44. Vlachopoulos C, "Increased arterial stiffness and impaired endothelial function in nonalcoholic fatty liver disease : a pilot study", Am J Hypertens, 23, pp.1183~1189 (2010)
  45. Agarwal AK, "Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes", J Assoc Physicians India, 59, pp.351~354 (2011)
  46. Mishra S, "A study of carotid atherosclerosis in patients with non-alcoholic fatty liver disease", Indian J Clin Biochem, 28, pp.79~83 (2013)
  47. Rampally V, "Determination of association between nonalcoholic fatty liver disease and carotid artery atherosclerosis among nondiabetic individuals", J Family Med Prim Care, 9, pp.1182~1186 (2020)
  48. Rasool A, "Nonalcoholic fatty liver disease as an independent risk factor for carotid atherosclerosis", Brain Circ, 3, pp.35~40 (2017)
  49. Thakur ML, "Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians", Atherosclerosis, 223, pp.507~511 (2012)
  50. Fadaei R, "Association of carotid intima media thickness with atherogenic index of plasma, apo B", apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease, 2019, pp.125, 19~24
  51. HanafiMG, "Correlation between non-alcoholic fatty liver disease and carotid Intima-Media thickness in patient with type II diabetes", Int J Osteoporos Metab Disord, 8, pp.35~41 (2015)
  52. Kamran B. Lankarani, "Common Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease: A Population-based Case-control Study", 대한소화기학회지, 62(6), pp.344~351 (2013), 대한소화기학회
  53. Mohammadi A, "Evaluation of atherosclerotic findings in patients with nonalcoholic fatty liver disease", Int J Gen Med, 4, pp.717~722 (2011)
  54. Mohammadi A, "Evaluation of relationship between grading of fatty liver and severity of atherosclerotic finding", Int J Clin Exp Med, 5, pp.251~256 (2012)
  55. Mohammadi A, "Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease", Vasc Health Risk Manag, 7, pp.661~665 (2011)
  56. Mohammadzadeh A, "Association of non-alcoholic fatty liver disease with increased carotid intima-media thickness considering other cardiovascular risk factors", Iran J Radiol, 16, pp.e14260~ (2019)
  57. Nahandi MZ, "Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis", Gastroenterol Hepatol Bed Bench, 7, pp.55~62 (2014)
  58. Fracanzani AL, "Carotid artery intima-media thickness in nonalcoholic fatty liver disease", Am J Med, 121, pp.72~78 (2008)
  59. Fracanzani AL, "Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up", Atherosclerosis, 246, pp.208~213 (2016)
  60. Mantovani A, "Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes", Int J Cardiol, 225, pp.387~391 (2016)
  61. Neri S, "Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic fatty liver disease", Int J Angiol, 20, pp.149~156 (2011)
  62. Ramilli S, "Carotid lesions in outpatients with nonalcoholic fatty liver disease", World J Gastroenterol, 15, pp.4770~4774 (2009)
  63. Salvi P, "Increased arterial stiffness in nonalcoholic fatty liver disease : the Cardio-GOOSE study", J Hypertens, 28, pp.1699~1707 (2010)
  64. Targher G, "Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C", J Hepatol, 46, pp.1126~1132 (2007)
  65. Targher G, "Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease", Diabetes Care, 29, pp.1325~1330 (2006)
  66. Targher G, "Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease", Arterioscler Thromb Vasc Biol, 25, pp.2687~2688 (2005)
  67. Hamaguchi M, "Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease", World J Gastroenterol, 13, pp.1579~1584 (2007)
  68. Mori T, "Non-alcoholic fatty liver disease frequency and associated factors at admission of acute stroke", Hepatol Int, 16, pp.81~88 (2022)
  69. Omar N, "Relationships between severity of steatosis with glycemic control and carotid intima-media thickness among diabetic patients with ischemic heart disease", J Res Med Sci, 25, pp.64~ (2020)
  70. Tan EC, "Association between non-alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community", JGH Open, 3, pp.117~125 (2018)
  71. Silaghi CA, "Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease", Med Ultrason, 17, pp.300~307 (2015)
  72. Stolic RV, "Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients", Int Urol Nephrol, 48, pp.883~889 (2016)
  73. Hong HC, "The synergistic impact of nonalcoholic fatty liver disease and metabolic syndrome on subclinical atherosclerosis", Clin Endocrinol(Oxf), 84, pp.203~209 (2016)
  74. 강지훈, "Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients", Journal of Cardiovascular Imaging, 20(3), pp.126~133 (2012), 한국심초음파학회
  75. Kim HC, "Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome", Atherosclerosis, 204, pp.521~525 (2009)
  76. Kim JH, "Carotid intima-media thickness is increased not only in non-alcoholic fatty liver disease patients but also in alcoholic fatty liver patients", Digestion, 84, pp.149~155 (2011)
  77. Kim SK, "Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance", J Clin Endocrinol Metab, 99, pp.1879~1884 (2014)
  78. Moon SH, "Association between nonalcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography", Angiology, 66, pp.472~480 (2015)
  79. Serra-Planas E, "Low prevalence of non-alcoholic fatty liver disease in patients with type 1 diabetes is associated with decreased subclinical cardiovascular disease", J Diabetes, 9, pp.1065~1072 (2017)
  80. Zizza A, "Atherosclerosis is associated with a higher risk of hepatic steatosis in HIV-infected patients", J Prev Med Hyg, 58, pp.E219~E224 (2017)
  81. Wang CC, "Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease", J Gastroenterol Hepatol, 24, pp.1411~1416 (2009)
  82. Arinc H, "Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis", Ups J Med Sci, 118, pp.228~234 (2013)
  83. Ayaz T, "The relation between carotid intima media thickness and serum osteoprotegerin levels in nonalcoholic fatty liver disease", Metab Syndr Relat Disord, 12, pp.283~289 (2014)
  84. Aygun C, "Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease", Dig Dis Sci, 53, pp.1352~1357 (2008)
  85. Başar O, "Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis", Herz, 38, pp.417~422 (2013)
  86. Cetindağlı I, "Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease : association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation", Clin Res Hepatol Gastroenterol, 41, pp.516~524 (2017)
  87. Colak Y, "Relation of epicardial adipose tissue and carotid intimamedia thickness in patients with nonalcoholic fatty liver disease", Eur J Gastroenterol Hepatol, 24, pp.613~618 (2012)
  88. Colak Y, "Assessment of endothelial function in patients with nonalcoholic fatty liver disease", Endocrine, 43, pp.100~107 (2013)
  89. Kemaloglu C, "Non alcoholic fatty liver disease is a predictor of subclinical carotid atherosclerosis in the presence of metabolic syndrome", Nepal Heart J, 16, pp.39~45 (2019)
  90. Kilciler G, "Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease", Ups J Med Sci, 115, pp.253~259 (2010)
  91. Kucukazman M, "Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease", Eur J Gastroenterol Hepatol, 25, pp.147~151 (2013)
  92. Ozturk K, "Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men", Atherosclerosis, 240, pp.380~386 (2015)
  93. Gill C, "Frequency of nonalcoholic fatty liver disease and subclinical atherosclerosis among young mexican americans", Am J Cardiol, 119, pp.1717~1722 (2017)
  94. Oni E, "Nonalcoholic fatty liver disease is associated with arterial distensibility and carotid intima-media thickness : (from the multi-ethnic study of atherosclerosis)", Am J Cardiol, 124, pp.534~538 (2019)
  95. Brea A, "Nonalcoholic fatty liver disease is associated with carotid atherosclerosis : a case-control study", Arterioscler Thromb Vasc Biol, 25, pp.1045~1050 (2005)
  96. Siddiqui MS, "Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis", Gastroenterology, 145, pp.1271~1279 (2013)
  97. Siddiqui MS, "Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile", Clin Gastroenterol Hepatol, 13, pp.1000~1008 (2015)
  98. Patel S, "Association between lipoprotein particles and atherosclerotic events in nonalcoholic fatty liver disease", Clin Gastroenterol Hepatol, 19, pp.2202~2204 (2021)
  99. Rockman CB, "The prevalence of carotid artery stenosis varies significantly by race", J Vasc Surg, 57, pp.327~337 (2013)
  100. Liu J, "Association of carotid atherosclerosis and recurrent cerebral infarction in the Chinese population : a meta-analysis", Neuropsychiatr Dis Treat, 13, pp.527~533 (2017)
  101. Ammirati E, "Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularization", Int J Cardiol Heart Vasc, 30, pp.100619~ (2020)
  102. Haacke C, "Long-term outcome after stroke : evaluating health-related quality of life using utility measurements", Stroke, 37, pp.193~198 (2006)
  103. Choudhary NS, "Screening of cardiovascular disease in nonalcoholic fatty liver disease : whom and how?", J Clin Exp Hepatol, 9, pp.506~514 (2019)
  104. European Association for the Study of the Liver(EASL), "EASL-EASDEASO clinical practice guidelines for the management of nonalcoholic fatty liver disease", Obes Facts, 9, pp.65~90 (2016)
  105. Bots ML, "Intima media thickness as a surrogate marker for generalised atherosclerosis", Cardiovasc Drugs Ther, 16, pp.341~351 (2002)
  106. Kasliwal RR, "Carotid intimamedia thickness : current evidence, practices, and Indian experience", Indian J Endocrinol Metab, 18, pp.13~22 (2014)
  107. Jahromi AS, "Sensitivity and specificity of color duplex ultrasound measurement in the estimation of internal carotid artery stenosis : a systematic review and metaanalysis", J Vasc Surg, 41, pp.962~972 (2005)
  108. Zaidi NR, "Diagnostic accuracy of carotid intima media thickness by B-mode ultrasonography in coronary artery disease patients", Arch Med Sci Atheroscler Dis, 5, pp.e79~e84 (2020)
  109. Jonathan Zhi Kai Toh, "A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease", Clinical Gastroenterology and Hepatology, 20(11), pp.2462~2473.e10 (2022), Elsevier BV[DOI]

관련 논문AI추천

Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients강지훈, 구자준, 김경년, 김동준, 김성만, 김재준, 김태익, 문병수, 심재용, 이자영, 이현국, 이혜리, 조경임, 지준형한국심초음파학회 · Journal of Cardiovascular Imaging2012 · 제20권 제3호Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?Jian-Gao Fan, Qian Jin, Rui-Xu Yang대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제3호Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis강민경, 강병훈, 김종호연세대학교의과대학 · Yonsei Medical Journal2015 · 제56권 제5호심혈관계 위험인자로서의 비알코올지방간질환; 경동맥 동맥경화와의 상관관계강진화, 김동희, 김영선, 김충현, 박민정, 이효석, 임선희, 최수연대한간학회 · Clinical and Molecular Hepatology2008 · 제14권 제1호Risk Assessment for Carotid Atherosclerosis in Asymptomatic Patients with Metabolic Dysfunction-Associated Steatotic Liver DiseaseBae Suh Eun, Chang Hye-Sook, Choe Jaewon, Kim Jaeil, Lee Hyo Jeong, Lee Ji Young, Park Hana, Park Hye Won, Park Sungwon, Shim Ju Hyun거트앤리버 소화기연관학회협의회 · Gut and Liver2026 · 제20권 제1호Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease박상민, Chang Jooyoung, Choi Seulggie, Kim Sung Min, Kim Won, Lee Gyeongsil, Oh Yun Hwan, Seogsong Jeong, Son Joung Sik거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제4호

이 간행물의 다른 논문 (18건)

Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma성필수pp. 333-350The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infectionYoung-Joo Jin, 조순구, Jung Hwan Yu, Jin-Woo Leepp. 351-361Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound이정민, Jeong Hee Yoon, Tae-Hyung Kim, Junghoan Parkpp. 362-379Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?Dong Hyun Sinn, Myung Ji Gohpp. 380-395Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevanceMina Komutapp. 396-407
원문 보기